The U.S. Food and Drug Administration recently rescinded its emergency use authorization for hydroxychloroquine to treat COVID-19. Based on new evidence, the agency said that the potential benefits of taking hydroxychloroquine and chloroquine to treat COVID-19 did not outweigh the risks (The New York Times).